Skip to content

Study · Animal study (in vivo) · mouse · 2007

5 results

Immunopharmacological properties of noopept.

Kovalenko LP, Shipaeva EV, Alekseeva SV, Pronin AV, Durnev AD, Durnev AD, Gudasheva TA, Ostrovskaja RU, Seredenin SB

Bulletin of experimental biology and medicine1 Jul 2007

PMID18256750 (opens in a new tab)DOI10.1007/s10517-007-0251-3 (opens in a new tab)PepBankPUB-18256750
Publisher pagePubMedAsk about this study
Jump to 5 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

5 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In mice, noopept enhanced peritoneal macrophage phagocytic activity.

    In plain wordsIn mice, noopept increased macrophage activity.

    Peptide
    Noopept (omberacetam)
    Outcome
    IncreaseMacrophage phagocytic activity
    Study

    mousen: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Noopept, a peptide analog of piracetam, enhanced phagocytic activity of mouse peritoneal macrophages, stimulated humoral and cellular immune response to various antigens, and markedly increased spontaneous proliferative activity of splenocytes.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In mice, noopept stimulated humoral immune responses to various antigens.

    In plain wordsIn mice, noopept increased humoral immune responses.

    Peptide
    Noopept (omberacetam)
    Outcome
    IncreaseHumoral immune response
    Study

    mousen: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Noopept, a peptide analog of piracetam, enhanced phagocytic activity of mouse peritoneal macrophages, stimulated humoral and cellular immune response to various antigens, and markedly increased spontaneous proliferative activity of splenocytes.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In mice, noopept stimulated cellular immune responses to various antigens.

    In plain wordsIn mice, noopept increased cellular immune responses.

    Peptide
    Noopept (omberacetam)
    Outcome
    IncreaseCellular immune response
    Study

    mousen: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Noopept, a peptide analog of piracetam, enhanced phagocytic activity of mouse peritoneal macrophages, stimulated humoral and cellular immune response to various antigens, and markedly increased spontaneous proliferative activity of splenocytes.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In mice, noopept markedly increased spontaneous splenocyte proliferation.

    In plain wordsIn mice, noopept increased spontaneous spleen cell proliferation.

    Peptide
    Noopept (omberacetam)
    Outcome
    IncreaseSplenocyte spontaneous proliferation
    Study

    mousen: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Noopept, a peptide analog of piracetam, enhanced phagocytic activity of mouse peritoneal macrophages, stimulated humoral and cellular immune response to various antigens, and markedly increased spontaneous proliferative activity of splenocytes.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In animals with cyclophosphamide-induced secondary immune deficiency, noopept exhibited immunocorrector properties.

    In plain wordsIn animals with drug-induced immune deficiency, noopept showed immune-correcting properties.

    Peptide
    Noopept (omberacetam)
    Outcome
    Direction not reportedImmune correction
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    In animals with secondary immune deficiency caused by cyclophosphamide, noopept exhibited immunocorrector properties.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.